Analystreport

Calithera Biosciences, Inc. (NASDAQ: CALA) had its price target lowered by analysts at SVB Leerink LLC from $3.00 to $2.00. They now have an "outperform" rating on

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com